{"id":"W2975900312","doi":"10.1182/blood.v130.suppl_1.1861.1861","title":"A Phase Ib/II Trial of Selinexor Combined with Lenalidomide and Low Dose Dexamethasone in Patients with Relapsed / Refractory Multiple Myeloma","year":2017,"lang":"en","type":"article","venue":"Blood","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Princess Margaret Cancer Centre; Dalhousie University; Royal Victoria Hospital; University of Toronto; CancerCare Manitoba; Vancouver General Hospital","funders":"","keywords":"Lenalidomide; Tolerability; Neutropenia; Medicine; Regimen; Dexamethasone; Internal medicine; Multiple myeloma; Febrile neutropenia; Oncology; Phases of clinical research; Pomalidomide; Refractory (planetary science); Gastroenterology; Pharmacology; Adverse effect; Clinical trial; Toxicity; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001616145,0.001913495,0.002379787,0.0005511913,0.0004577746,0.001198014,0.001114665,0.001319579,0.00552954],"category_scores_gemma":[0.00070334,0.0008024991,0.001652407,0.0003903263,0.001282988,0.0009890698,0.0005334752,0.003579438,0.001112041],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001245319,"about_ca_system_score_gemma":0.001727319,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001020052,"about_ca_topic_score_gemma":0.003124911,"domain_scores_codex":[0.9995122,0.0002322785,0.00002622445,0.0000945479,0.00003855998,0.00009617219],"domain_scores_gemma":[0.9994658,0.0000628632,0.00009048228,0.00004504454,0.00002898186,0.0003069875],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8408679,0.07820193,0.004302702,0.0007362796,0.001142608,0.0002606103,0.0003073022,0.002068171,0.02110619,0.000299,0.002782265,0.04792507],"study_design_scores_gemma":[0.612117,0.378747,0.004801198,0.00002932161,0.0002419834,0.0001354323,0.000057301,0.0006712049,0.001213003,0.0001570671,0.001808278,0.00002121958],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9886569,0.00165118,0.0003284748,0.0006439988,0.0001966721,0.004896309,0.001115146,0.0001117988,0.002399437],"genre_scores_gemma":[0.986953,0.001439212,0.001297407,0.001164977,0.0002063033,0.003756905,0.00168959,0.00002110522,0.003471598],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00552954,"threshold_uncertainty_score":0.01849818,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006399400487065476,"score_gpt":0.2231335860805875,"score_spread":0.216734185593522,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}